Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Nature Communications|May 19, 2025
Epstein-Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathwaysSusanne Delecluse, Francesco Baccianti, Manon Zala, et al.
Cellular Immunology|December 31, 2020
Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot studyChristoffer Gebhardt, Sonja C S Simon, Rebekka Weber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, et al.
The American Journal of Gastroenterology|December 14, 2007
Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis genePeter Felderbauer, Elias Karakas, Volker Fendrich, et al.
Molecular Imaging and Biology|December 23, 2017
Role of CT Density in PET/CT-Based Assessment of LymphomaPaul Flechsig, Christina Walker, Clemens Kratochwil, et al.
Breast Cancer Research and Treatment|January 18, 2018
Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancerJie Cheng, Tim Holland-Letz, Markus Wallwiener, et al.
Immunology and Cell Biology|April 4, 2007
Anti-BDCA-4 (neuropilin-1) antibody can suppress virus-induced IFN-alpha production of plasmacytoid dendritic cellsEvelin Grage-Griebenow, Stefan Löseke, Marion Kauth, et al.
International Journal of Molecular Sciences|March 23, 2018
Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control IndividualsXue Cao, Qiuqiong Tang, Tim Holland-Letz, et al.
Vascular Medicine (London, England)|July 10, 2007
Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nursesTim Holland-Letz, Heinz G Endres, Stefanie Biedermann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate DehydrogenaseHendrik Rathke, Tim Holland-Letz, Walter Mier, et al.
Pageof 17